Abbott Laboratories (ABT)

Depreciation & Amortization

$3.33B

TTM · Period ending: · USD

ABT logo

ABT Depreciation & Amortization

Latest reported$3.33B
ABT TTM Depreciation & Amortization ($355.90M → $3.33B)
High-resolution chart · PNG

ABT depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
3,326,000,000
3,090,000,000
3,116,000,000
3,131,000,000
3,141,000,000
3,169,000,000
3,218,000,000
3,224,000,000
3,247,000,000
3,242,000,000
3,243,000,000
3,237,000,000
3,228,000,000
3,250,000,000
3,267,000,000
3,343,000,000
3,375,000,000
3,427,000,000
3,538,000,000
3,521,000,000
3,482,000,000
3,433,000,000
3,327,000,000
3,217,000,000
3,163,000,000
3,089,000,000
3,014,000,000
3,021,000,000
3,080,000,000
3,179,000,000
3,278,000,000
3,358,000,000
3,301,000,000
3,099,000,000
3,021,000,000
2,497,000,000
2,081,000,000
1,780,000,000
1,353,000,000
1,400,000,000
1,443,000,000
1,448,000,000
1,472,000,000
1,501,000,000
1,473,000,000
1,521,000,000
1,548,000,000
1,578,625,000
1,659,625,000
1,695,625,000
1,718,478,000
1,881,630,000
2,205,358,000
2,460,793,000
2,783,207,000
2,842,859,000
2,921,517,000
3,041,494,000
3,043,894,000
3,105,043,000
2,943,681,000
2,807,471,000
2,624,305,000
2,462,080,000
2,325,770,000
2,187,966,000
2,089,510,000
1,964,712,000
1,922,558,000
1,851,020,000
1,838,829,000
1,899,466,000
1,904,675,000
1,874,316,000
1,854,886,000
1,782,800,000
1,660,472,000
1,618,582,000
1,558,750,000
1,485,359,000
1,447,285,000
1,386,651,000
1,358,939,000
1,354,584,000
1,324,020,000
1,344,285,000
1,288,700,000
1,326,496,000
1,251,350,000
1,148,694,000
1,172,054,000
1,086,734,000
1,140,538,000
1,166,879,000
1,177,345,000
1,210,401,000
1,226,813,000
1,261,071,000
1,168,018,000
1,047,901,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.